New research has found that men who carry a common genetic variant are twice as likely to develop dementia in their lifetime ...

An online platform may help increase access to and reduce barriers associated with germline testing for individuals with cancer, according to findings presented at ASCO Annual Meeting.An analysis of ...

Science is for all of us and by all of us—it is humanity’s never-ending story, and it should be honored and protected.

The new ‘liquid biopsy’ test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, ...

New research has found that men who carry a common genetic variant are twice as likely to develop dementia in their lifetime ...

Children exposed to gestational diabetes in utero with a specific variation of a common gene are at a higher risk of becoming ...

Tens of thousands of patients with lung and breast cancer are to benefit from a “revolutionary” blood test on the NHS across England which can speed up access to targeted therapy. The new ‘liquid ...

The U.S. National Institutes of Health are collectively the world's biggest medical-research funding organization. The body ...

People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid ...

and who agreed to participate in research DNA banking, were included (N = 488). Personal and family cancer histories were collected and germline DNA was sequenced with NGS to identify mutations.

New research has found that men who carry a common genetic variant are twice as likely to develop dementia in their lifetime compared to women.

The new "liquid biopsy" test searches for tiny fragments of DNA that are shed by tumours into the bloodstream - it can ...